Antibody diversification and selection in the mature B-cell compartment

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 64, Issue , 1999, Pages 211-216

  Neuberger, M S ^a   Lanoue, A ^a   Ehrenstein, M R ^a   Batista, F D ^a   Sale, J E ^a   Williams, G T ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; GENE FUNCTION; GENE MUTATION; GENE SWITCHING; IMMUNE RESPONSE; PRIORITY JOURNAL; ANTIBODY DIVERSIFICATION; ARTICLE; BURKITT LYMPHOMA; CELL EXPANSION; CHROMOSOME PAIRING; DNA STRAND BREAKAGE; GENE REARRANGEMENT; GENETIC TRANSFECTION; GENETIC VARIABILITY; IMMUNOGLOBULIN DOMAIN; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; SOMATIC HYPERMUTATION;

ANTIBODY; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD22 ANTIGEN; COMPLEMENT; DNA DEPENDENT PROTEIN KINASE; DNA NUCLEOTIDYLEXOTRANSFERASE; GLYCOCONJUGATE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYSOZYME; PROTEIN MSH2; RNA POLYMERASE; SIALIC ACID;

EID: 0033497745     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1999.64.211     Document Type: Conference Paper

References (31)

1. Batista F.D. and Neuberger M.S. 1998. Affinity dependence of the B cell response to antigen: A threshold, a ceiling, and the importance of off-rate. Immunity 8: 751.
2. Betz A.G., Rada C., Pannell R., Milstein C, and Neuberger M.S. 1993. Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: Clustering, polarity, and specific hot spots. Proc. Natl. Acad. Sci. 90: 2385.
3. Boes M., Esau C., Fischer M.B., Schmidt T., Carroll M., and Chen J. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160: 4776.
4. Carter R.H. and Fearon D.T. 1992. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105.
5. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X.F., Besmer E., Kenter A., Rajewsky K., and Nussenzweig M.C. 1998. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17: 2404.
6. Chan V.W.F., Meng F., Soriano P., DeFranco A.L., and Lowell C.A.. 1997. Characterisation of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69.
7. Dénépoux S., Razanajaona D., Blanchard D., Meffre G., Capra J.D., Banchereau J., and Lebecque S. 1997. Induction of somatic mutation in a human B cell line in vitro. Immunity 6: 35.
8. Ehrenstein M.R. and Neuberger M.S. 1999. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: Parallels with somatic hypermutation. EMBO J. 18: 3484.
9. Ehrenstein M.R., O'Keefe T.L., Davies S.L., and Neuberger M.S. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. 95: 10089.
10. Fearon D.T. 1978. Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative pathway. Proc. Natl. Acad. Sci. 75: 1971.
11. Frey S., Bertocci B., Delbos F., Quint L., Weill J.C., and Reynaud C.A. 1998. Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process. Immunity 9: 127.
12. Hanasaki K., Varki A., Stamenkovic I., and Bevilacqua M.P. 1994. Cytokine-induced β-galactoside α-2,6-sialyltransferase in human endothelial cells mediates α-2,6-sialylation of adhesion molecules and CD22 ligands. J. Biol. Chem. 269: 10637.
13. Hibbs M.L., Tarlinton D.M., Armes J., Grail D., Hodgson G., Maglitto R., Stacker S.A., and Dunn A.R. 1995. Multiple defects in the immune system of Lyn-deficient mice culminating in autoimmune disease. Cell 83: 301.
14. Kazatchkine M.D., Fearon D.T., and Austen K.F. 1979. Human alternative complement pathway: Membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122: 75.
15. Manis J.P., Gu Y., Lansford R., Sonoda E., Ferrini R., Davidson L., Rajewsky K., and Alt F.W. 1998. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 187: 2081.
16. Milstein C., Neuberger M.S., and Staden R. 1998. Both DNA strands of antibody genes are hypermutation targets. Proc. Natl. Acad. Sci. 95: 8791.
17. Nishizumi H., Taniuchi I., Yamanashi Y., Kitamura D., Ilic D., Mon S., Watanabe T., and Yamamoto T. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549.
18. Nitschke L., Carsetti R., Ocker B., Köhler G., and Lamers M.C. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7: 133.
19. O'Keefe T.L., Williams G.T., Batista F.D., and Neuberger M.S. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189: 1307.
20. O'Keefe T.L., Williams G.T., Davies S.L., and Neuberger M.S. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 214: 798.
21. Otipoby K.L., Andersson K.B., Draves K.E., Klaus S.J., Farr A.G., Kerner J.D., Perlmutter R.M., Law C.-L., and Clark E.A. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384: 634.
22. Phung Q.H., Winter D.B., Cranston A., Tarone R.E., Bohr V.A., Fishel R., and Gearhart P.J. 1998. Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J. Exp. Med. 187: 1745.
23. Powell L.D., Sgroi D., Sjoberg E.R., Stamenkovic I., and Varki A. 1993. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with α-2,6-linked sialic acids that are required for recognition. J. Biol. Chem. 268: 7019.
24. Rada C., Ehrenstein M.R., Neuberger M.S., and Milstein C. 1998. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9: 135.
25. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., and Rice P.A. 1998. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae J. Exp. Med. 187: 743.
26. Rolink A., Melchers F., and Andersson J. 1996. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5: 319.
27. Sale J.E. and Neuberger M.S. 1998. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9: 859.
28. Sato S., Miller A.S., Inaoki M., Bock C.B., Jansen P.J., Tang M.L.K., and Tedder T.F. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 5: 551.
29. Shultz L.D. and Green M.C. 1976. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J. Immunol. 116: 936.
30. Stavnezer J. 1996. Antibody class switching. Adv. Immunol. 61: 79.
31. Wagner S.D., Popov A.V., Davies S.L., Xian J., Neuberger M.S., and Brüggemann M. 1994. The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci. Eur. J. Immunol. 24: 2672.